The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1180509
Abstract: Autoimmune hemolytic anemia (AIHA) is defined by increased erythrocyte turnover mediated by autoimmune mechanisms. While corticosteroids remain first-line therapy in most cases of warm-antibody AIHA, cold agglutinin disease is treated by targeting the underlying clonal… read more here.
Keywords: choice new; treatments autoimmune; hemolytic anemia; new treatments ... See more keywords